NM_130468.4(CHST14):c.527_530delinsGACAG (p.Val176fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type|not provided
β
β
ββ2026β Residue 176
NM_130468.4(CHST14):c.156_166del (p.Ser53fs)Pathogenic
not provided|Ehlers-Danlos syndrome, musculocontractural type
β
β
ββ2025β Residue 53
NM_130468.4(CHST14):c.878A>G (p.Tyr293Cys)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type|not provided|Ehlers-Danlos syndrome, musculocontractural type 1|Cardiovascular phenotype
β
β
ββ2025β Residue 293
NM_130468.4(CHST14):c.171del (p.Leu58fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type|not provided
β
β
ββ2025β Residue 58
NM_130468.4(CHST14):c.610C>T (p.Gln204Ter)Pathogenic
Cardiovascular phenotype|Ehlers-Danlos syndrome, musculocontractural type
β
β
ββ2025β Residue 204
NM_130468.4(CHST14):c.784G>A (p.Glu262Lys)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type|not provided|Ehlers-Danlos syndrome, musculocontractural type 1|CHST14-related disorder
β
β
ββ2025β Residue 262
NM_130468.4(CHST14):c.755_851del (p.Ser252fs)Pathogenic
not provided|Ehlers-Danlos syndrome, musculocontractural type
β
β
ββ2023β Residue 252
NM_130468.4(CHST14):c.958C>T (p.Arg320Ter)Likely pathogenic
not provided|Ehlers-Danlos syndrome, musculocontractural type|Cardiovascular phenotype
β
β
ββ2023β Residue 320
NM_130468.4(CHST14):c.494del (p.Val165fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2026β Residue 165
NM_130468.4(CHST14):c.597dup (p.Arg200fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2025β Residue 200
NM_130468.4(CHST14):c.783del (p.Glu262fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2025β Residue 262
NM_130468.4(CHST14):c.730del (p.Arg244fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2025β Residue 244
NM_130468.4(CHST14):c.181G>T (p.Glu61Ter)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2025β Residue 61
NM_130468.4(CHST14):c.201_202del (p.Glu67fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2024β Residue 67
NM_130468.4(CHST14):c.638G>C (p.Arg213Pro)Likely pathogenic
Ehlers-Danlos syndrome, musculocontractural type|Ehlers-Danlos syndrome, musculocontractural type 1
β
βββ2024β Residue 213
NM_130468.4(CHST14):c.85_95dup (p.Leu34fs)Likely pathogenic
Ehlers-Danlos syndrome, musculocontractural type 1
β
βββ2024β Residue 34
NM_130468.4(CHST14):c.626T>C (p.Phe209Ser)Likely pathogenic
Ehlers-Danlos syndrome, musculocontractural type 1
β
βββ2024β Residue 209
NM_130468.4(CHST14):c.53_57del (p.Leu18fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2024β Residue 18
NM_130468.4(CHST14):c.88del (p.Ala30fs)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type
β
βββ2024β Residue 30
NM_130468.4(CHST14):c.922C>T (p.Gln308Ter)Pathogenic
Ehlers-Danlos syndrome, musculocontractural type 1
β
βββ2023β Residue 308